Future Science Group

Georgi Makin, Editor of 3DMedNet, is joined by Jacob Koffler (University of California San Diego; CA, USA) as they discuss how 3D printing is being used in spinal cord injury research. As part of 3DMedNet’s special feature - 3D in focus: applications in neuro R&D – Georgi and Jacob explore 3D printing in neurology and neuroscience. Find out more: Georgi Makin is the Editor of 3DMedNet (www.3dmedne...

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Greg Mitchelotti of Metabolon about metabolomics, its potential applications in precision medicine and the new $4 million research collaboration with the Canadian Longitudinal Study of Aging and other Canadian institutions to identify biomarkers for frailty.

In this interview, hear from Catharina Brandsten, Head of Tissue Establishment and Kristina Runeberg, Site Head, at Takara Bio Europe, about deriving ethical and GMP-grade embryonic stem cells.

Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry technology, in this interview with Neil Walsh (SCIEX; MA, USA).

Understanding automation in cell therapy manufacturing: an interview with Markus Gershater by Taylor & Francis Group

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Theo Roth from the University of California San Francisco Marson Lab (CA, USA). Having recently made headlines for his work in T-cell engineering, Theo takes us through his groundbreaking CRISPR research, its potential impacts in CAR-T cell therapy and further afield, whilst also tackling the evolving ethics in gen...

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.

Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories).

Abigail Sawyer and Tristan Free, from the BioTechniques digital team, speak to Head of Open Access Publishing at Future Science Group, Francesca Lake about antibodies: their advantages and flaws, pitfalls in their use and selecting the right antibodies for an experiment.

Eric Bonner (Eurofins) discusses the techniques he uses for assessing immunogenicity, key challenges and what the future may hold for the field in this podcast, exclusive to the Bioanalysis Zone Spotlight on immunogenicity. You can find many more resources on immunogenicity via the immunogenicity Spotlight pages on Bioanalysis Zone: http://bit.ly/2J6w15F

Georgi Makin, Editor of 3DMedNet, is joined by Jade Parker (Oncology Central) and Shana Cook (Milwaukee School of Engineering) as they discuss how patient experience with surgery can be improved with 3D printing, drawing from Shana’s personal experience 3D printing her own tumor from MRI data, following surgical resection of retroperitoneal leiomyosarcoma. Note: > At 5:11, Cook left Benedictine Un...

Find out more about the role of exosomes in flow cytometry studies in this interview Joyce Slusser (KCAS; KS, USA).

Find out more about current challenges and recent developments in seen in the field of flow cytometry in this interview with Clara Brando and Ted Baginski (Eurofins; MO, USA).

In this podcast, Hugh Davis (Frontage Laboratories; PA, USA) discusses the challenges associated with gene therapy and what the future may hold for the field.

Abigail Sawyer and Tristan Free from the BioTechniques editorial team talk to Assistant Editor, Jenny Straiton about her recent Tech news piece on Cerebral Organoids and the history of neuroscience.

Find out more about the challenges associated with CAR-T cell immunotherapies and what the future may hold for the field in this interview with Marco Ruella.

Abigail Sawyer and Tristan Free from the BioTechniques editorial team discuss the recently published tech news piece on unsustainability in the lab and the ways that some institutions are trying to address it.

Fake news, the reproducibility crisis and politics are all reasons why the public may distrust science. We spoke to Gareth Mitchell, host on the BBC World Service radio show Click and lecturer in Imperial College London's science communication department, to find out a little bit more about science communication.

In this interview Paul Wyatt, University of Dundee (Scotland) describes the work taking place at the Wellcome Center for Anti-Infectives Research into neglected tropical diseases.

Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS) - http://bit.ly/2OjaOX7

We spoke to Mark Behlke, the chief scientific officer of Integrated DNA Technologies (IA, USA), about the current limitations of CRISPR/Cas9 techniques and the potential of the novel HiFI Cas9 enzyme to resolve these limitations, as shown in a sickle cell disease-causing mutation.

In line with our October focus on healthcare-associated infections, we spoke to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance. Amy discussed her research on sink traps, toilets and wastewater, what solutions hospitals can use and antibiotic resistance in the broader context – including the role of infection prevention and...

Find out more about the flow cytometry in this Bioanalysis Zone interview with Christoph Eberle (Charles River Laboratories), as part of our 'In the Zone' feature. You can find out more about flow cytometry on the website, at: http://bit.ly/2RuwAKi

In this podcast, Roshaine Wijayatunga, Senior Editor for Oncology at Future Science Group speaks with Barbara Moss, a Patient Ambassador for Europacolon (UK) and Bowel Cancer UK. At the age of 52, in 2006, Barbara was diagnosed with Stage IV colorectal cancer of the colon, spread to the liver, and was told she had 3–5 months to live. Barbara is now an active campaigner and an active member of seve...

Since Zika broke into the news in 2016, new research has been uncovering more information about this virus – we spoke to Dustin Farr at the recent ASM Microbe meeting where he was presenting a poster on Zika infection in corneal cells.